Developer docs
API playgroundTry for free, no card

Search company profiles

Rodman & Renshaw

Full company profile

uuid0006pzz

Namestring
Rodman & Renshaw
Legal namestring
Rodman & Renshaw, LLC
Company typeenum
Private
Founded yearint
1951
Descriptiontext

Rodman & Renshaw, founded in 1951, is a privately held boutique investment bank headquartered at 600 Lexington Avenue in New York City. The firm provides equity and debt financing, mergers and acquisitions advisory, and related corporate finance services to growth companies, primarily in the healthcare, technology, and energy sectors, and serves as placement agent for public offerings, registered directs, private placements, PIPEs, and a range of other capital markets transactions.

The firm is organized around four core functions: investment banking, equity research, institutional sales, and corporate access. Its flagship technology platform is StockBlock, a proprietary web-based eECM (electronic capital markets) system that connects public company issuers with institutional investors and supports real-time capital formation. Equity research is led by Director of Research Michael G. King Jr. and Vice President Seema Sheoran, Ph.D., with the team's work cited by the Wall Street Journal, Financial Times, and Institutional Investor; the firm maintains relationships with over 1,000 institutional investors in the U.S., Europe, and Asia.

Rodman & Renshaw generates revenue primarily through transaction-based fees paid by issuers for placement agent services and through professional services fees for M&A advisory and strategic advisory engagements. As a registered broker-dealer (FINRA/SIPC member) and Delaware LLC with 51-100 employees, the firm has executed over 500 transactions over the past 25 years, ranking within the top 4 investment banks by transaction count per PlacementTracker (as of November 2024).

Short descriptiontext

Rodman & Renshaw is a privately held, New York-based boutique investment bank founded in 1951 that provides equity and debt financing, M&A advisory, and placement agent services to lower middle market growth companies, distributing through a proprietary StockBlock eECM platform and a network of 1,000+ institutional investors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
investment banking services, equity capital markets, mergers and acquisitions advisory, PIPE financing, equity research
Industry2 codes
1Public & PIPE Capital Raising Intermediation (IPO Follow-ons/Convertibles/PIPES)
CodeFSAEALALPrimaryYes
2Lower Middle-Market Business Brokerage
CodeFSAEAIABPrimaryNo
NAICS code3 codes
  • Investment Banking and Securities Intermediation52315
  • Securities, Commodity Contracts, and Other Financial Investments and Related Activities523
  • Portfolio Management and Investment Advice52394
SIC code2 codes
  • Security Brokers, Dealers & Flotation Companies6211
  • Investment Advice6282
Product category
Boutique Investment Banking
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Investment Banking / Placement Agent Fees
TypeTransaction Fee
Description

Rodman & Renshaw earns fees from acting as exclusive placement agent for securities offerings, including registered directs, public offerings, private placements, and PIPEs. Registered Representatives are compensated on successful completion of offerings.

rodmanandrenshaw.com
2Broker-Dealer Services
TypeTransaction Fee
Description

Compensation received from issuers in connection with securities offerings at the time of investment or on periodic basis. Revenue tied to successful transaction completion.

rodmanandrenshaw.com
3Strategic Advisory
TypeProfessional Services
Description

M&A advisory fees for mergers, acquisitions, and restructurings for public and private companies.

rodmanandrenshaw.com
4Capital Markets Transaction Fees
TypeTransaction Fee
Description

Revenue from follow-ons, bought deals, at-the-market transactions (ATMs), S-1 public offerings, Regulation A offerings, and warrant inducements.

rodmanandrenshaw.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Transaction-based compensation
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

Fees, expenses, or compensation received from Issuers in connection with offerings. All fees disclosed in offering documents. No direct charges to investors.

rodmanandrenshaw.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Rodman & Renshaw is a boutique investment bank providing equity and debt financing, mergers and acquisitions advisory, and strategic advisory services to lower middle market growth companies across healthcare, technology, and energy sectors. The firm acts as a placement agent for registered directs, public offerings, private placements, and PIPEs, and operates a proprietary StockBlock electronic capital markets (eECM) platform that connects public company issuers with institutional investors for real-time capital formation. Complementary offerings include equity research distribution, institutional sales coverage, and corporate access non-deal road shows.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Top 4 investment bank by transaction count with 500+ transactions executed over 25 years
+1 more record
Product overview1 text field

Rodman & Renshaw is a boutique investment bank offering a comprehensive suite of financial services built around its proprietary StockBlock platform. The core offering consists of Investment Banking services (capital markets, M&A advisory, debt/equity financing) and Equity Research, complemented by Institutional Sales, Corporate Access, and Strategic Advisory divisions. StockBlock serves as the proprietary eECM platform connecting issuers seeking capital with institutional investors, enabling real-time negotiation and capital formation. The firm has executed over 500 transactions in 25 years, ranking among the top 4 investment banks by transaction volume.

Product and service6 records
1StockBlock
CategoryElectronic Capital Markets Platform
Description

Proprietary web-based electronic capital markets (eECM) platform that connects public company issuers with institutional investors, enabling real-time negotiation and capital formation for securities offerings.

2Investment Banking Services
CategoryCapital Markets and Advisory
Description

Equity and debt financing, mergers and acquisitions support, and capital markets services including follow-ons, registered directs, bought deals, at-the-market transactions, S-1 public offerings, Regulation A offerings, and PIPEs for public and private companies.

3Equity Research
CategoryInvestment Research
Description

Biotechnology and healthcare-focused equity research coverage from a team of Ph.D. and industry veteran analysts, followed by 1,000+ institutional clients and cited by the Wall Street Journal, Financial Times, and Institutional Investor.

4Institutional Sales
CategorySales and Trading
Description

Experienced sales staff maintaining direct relationships with 1,000+ institutional investors across the U.S., Europe, and Asia to support their participation in growth-company securities offerings.

5Corporate Access
CategoryInvestor Relations and Corporate Access
Description

After-market support organizing non-deal road shows for industry leaders and emerging companies to foster relationships between issuer clients and the institutional investor network.

6Strategic Advisory
CategoryMergers and Acquisitions Advisory
Description

M&A and strategic advisory services for public and private companies across capital raises, mergers and acquisitions, and restructurings.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or Integration
Description

StockBlock is Rodman & Renshaw's proprietary web-based eECM (electronic capital markets) platform that connects public company issuers with institutional investors. The platform empowers issuers to raise capital by enabling real-time negotiation with well-suited institutional investors, providing greater control over the capital formation process.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Oppenheimer & Co. is a larger, broader financial services firm offering investment banking, equity research, and institutional sales with overlapping small-cap and mid-cap issuer coverage—larger and more diversified than Rodman.

TypeDirect peer
Description

Maxim Group is a boutique investment bank and broker-dealer providing investment banking, equity research, and institutional sales—closely overlapping Rodman's full service offering for small-cap issuers.

TypeDirect peer
Description

EF Hutton is a boutique investment bank offering capital markets, advisory, and institutional sales services to small and mid-cap companies—closely comparable in target market and service breadth.

TypeBroad incumbent
Description

B. Riley Financial is a diversified financial services firm offering investment banking, capital markets, and research with meaningful overlap in small-cap capital markets—broader scope but competing for similar mandates.

TypeDirect peer
Description

Aegis Capital is a boutique broker-dealer providing investment banking, equity research, and institutional sales—directly comparable in service mix and small-cap issuer focus.

TypeDirect peer
Description

Ladenburg Thalmann operated as a comparable boutique investment bank with similar services in capital markets, research, and advisory for small and mid-cap issuers before its acquisition.

TypeDirect peer
Description

Roth Capital Partners is a closely comparable boutique investment bank specializing in PIPE/registered direct offerings, equity research, and institutional sales for small-cap and mid-cap companies, with comparable healthcare/biotech research franchise.

TypeBroad incumbent
Description

Jefferies is a mid-market focused full-service investment bank with substantially broader scale, comparable institutional sales and small-cap capital markets capabilities, but serving larger mandates than Rodman's boutique franchise.

TypeDirect peer
Description

ThinkEquity is a boutique investment bank focused on capital markets, equity research, and institutional sales for emerging growth companies—a near-twin of Rodman's lower middle market positioning.

TypeDirect peer
Description

A.G.P. is a direct peer operating as a boutique broker-dealer focused on PIPE transactions, equity research, and institutional sales for small and mid-cap issuers—overlapping directly in core service lines and target market.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment2 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Rodman & Renshaw

Boutique Investment Bankingrodmanandrenshaw.com

Rodman & Renshaw is a privately held, New York-based boutique investment bank founded in 1951 that provides equity and debt financing, M&A advisory, and placement agent services to lower middle market growth companies, distributing through a proprietary StockBlock eECM platform and a network of 1,000+ institutional investors.

What Rodman & Renshaw does

Rodman & Renshaw, founded in 1951, is a privately held boutique investment bank headquartered at 600 Lexington Avenue in New York City. The firm provides equity and debt financing, mergers and acquisitions advisory, and related corporate finance services to growth companies, primarily in the healthcare, technology, and energy sectors, and serves as placement agent for public offerings, registered directs, private placements, PIPEs, and a range of other capital markets transactions.

The firm is organized around four core functions: investment banking, equity research, institutional sales, and corporate access. Its flagship technology platform is StockBlock, a proprietary web-based eECM (electronic capital markets) system that connects public company issuers with institutional investors and supports real-time capital formation. Equity research is led by Director of Research Michael G. King Jr. and Vice President Seema Sheoran, Ph.D., with the team's work cited by the Wall Street Journal, Financial Times, and Institutional Investor; the firm maintains relationships with over 1,000 institutional investors in the U.S., Europe, and Asia.

Rodman & Renshaw generates revenue primarily through transaction-based fees paid by issuers for placement agent services and through professional services fees for M&A advisory and strategic advisory engagements. As a registered broker-dealer (FINRA/SIPC member) and Delaware LLC with 51-100 employees, the firm has executed over 500 transactions over the past 25 years, ranking within the top 4 investment banks by transaction count per PlacementTracker (as of November 2024).

Rodman & Renshaw firmographics

Firmographics
Name
Rodman & Renshaw
Legal name
Rodman & Renshaw, LLC
Website
https://rodmanandrenshaw.com
Company type
Private
Founded year
1951
Operating status
Operating
Headcount range
51–100 employees
Short description
Rodman & Renshaw is a privately held, New York-based boutique investment bank founded in 1951 that provides equity and debt financing, M&A advisory, and placement agent services to lower middle market growth companies, distributing through a proprietary StockBlock eECM platform and a network of 1,000+ institutional investors.
Ownership category
akta.pro rank

Rodman & Renshaw industry classification

Industry
Product category
Boutique Investment Banking
NAICS
Investment Banking and Securities Intermediation (52315), Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523), Portfolio Management and Investment Advice (52394)
SIC
Security Brokers, Dealers & Flotation Companies (6211), Investment Advice (6282)
akta.pro primary industry
Public & PIPE Capital Raising Intermediation (IPO Follow-ons/Convertibles/PIPES) (FSAEALAL)
akta.pro secondary industry
Lower Middle-Market Business Brokerage (FSAEAIAB)

Keywords

  • Investment banking services
  • Equity capital markets
  • Mergers and acquisitions advisory
  • PIPE financing
  • Equity research

Where Rodman & Renshaw is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Rodman & Renshaw business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Investment Banking / Placement Agent Fees: Rodman & Renshaw earns fees from acting as exclusive placement agent for securities offerings, including registered directs, public offerings, private placements, and PIPEs. Registered Representatives are compensated on successful completion of offerings.
  2. Broker-Dealer Services: Compensation received from issuers in connection with securities offerings at the time of investment or on periodic basis. Revenue tied to successful transaction completion.
  3. Strategic Advisory: M&A advisory fees for mergers, acquisitions, and restructurings for public and private companies.
  4. Capital Markets Transaction Fees: Revenue from follow-ons, bought deals, at-the-market transactions (ATMs), S-1 public offerings, Regulation A offerings, and warrant inducements.

Pricing tiers

ModelBillingPrice
Transaction based/ take ratePay-as-you-goTransaction-based compensation

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Rodman & Renshaw product offering

Product offering

Core offering

Rodman & Renshaw is a boutique investment bank providing equity and debt financing, mergers and acquisitions advisory, and strategic advisory services to lower middle market growth companies across healthcare, technology, and energy sectors. The firm acts as a placement agent for registered directs, public offerings, private placements, and PIPEs, and operates a proprietary StockBlock electronic capital markets (eECM) platform that connects public company issuers with institutional investors for real-time capital formation. Complementary offerings include equity research distribution, institutional sales coverage, and corporate access non-deal road shows.

Product overview

Rodman & Renshaw is a boutique investment bank offering a comprehensive suite of financial services built around its proprietary StockBlock platform. The core offering consists of Investment Banking services (capital markets, M&A advisory, debt/equity financing) and Equity Research, complemented by Institutional Sales, Corporate Access, and Strategic Advisory divisions. StockBlock serves as the proprietary eECM platform connecting issuers seeking capital with institutional investors, enabling real-time negotiation and capital formation. The firm has executed over 500 transactions in 25 years, ranking among the top 4 investment banks by transaction volume.

Differentiator

Problem solved

Functional benefit

Products and services

  • StockBlock Proprietary web-based electronic capital markets (eECM) platform that connects public company issuers with institutional investors, enabling real-time negotiation and capital formation for securities offerings.
  • Investment Banking Services Equity and debt financing, mergers and acquisitions support, and capital markets services including follow-ons, registered directs, bought deals, at-the-market transactions, S-1 public offerings, Regulation A offerings, and PIPEs for public and private companies.
  • Equity Research Biotechnology and healthcare-focused equity research coverage from a team of Ph.D. and industry veteran analysts, followed by 1,000+ institutional clients and cited by the Wall Street Journal, Financial Times, and Institutional Investor.
  • Institutional Sales Experienced sales staff maintaining direct relationships with 1,000+ institutional investors across the U.S., Europe, and Asia to support their participation in growth-company securities offerings.
  • Corporate Access After-market support organizing non-deal road shows for industry leaders and emerging companies to foster relationships between issuer clients and the institutional investor network.
  • Strategic Advisory M&A and strategic advisory services for public and private companies across capital raises, mergers and acquisitions, and restructurings.

Quantifiable outcome

  • Top 4 investment bank by transaction count with 500+ transactions executed over 25 years
  • +1 more outcomes

Companies that use Rodman & Renshaw

Customer profile

Segments3 records

Ideal customer profiles2 records

Rodman & Renshaw technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Rodman & Renshaw partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • StockBlock (Internal Platform)coreTechnology or IntegrationStockBlock is Rodman & Renshaw's proprietary web-based eECM (electronic capital markets) platform that connects public company issuers with institutional investors. The platform empowers issuers to raise capital by enabling real-time negotiation with well-suited institutional investors, providing greater control over the capital formation process.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Rodman & Renshaw competitors and assessment

Company assessment

Broad incumbents

  • Oppenheimer & Co. Oppenheimer & Co. is a larger, broader financial services firm offering investment banking, equity research, and institutional sales with overlapping small-cap and mid-cap issuer coverage—larger and more diversified than Rodman.
  • B. Riley Financial: B. Riley Financial is a diversified financial services firm offering investment banking, capital markets, and research with meaningful overlap in small-cap capital markets—broader scope but competing for similar mandates.
  • Jefferies Financial Group: Jefferies is a mid-market focused full-service investment bank with substantially broader scale, comparable institutional sales and small-cap capital markets capabilities, but serving larger mandates than Rodman's boutique franchise.

Direct peers

  • Maxim Group: Maxim Group is a boutique investment bank and broker-dealer providing investment banking, equity research, and institutional sales—closely overlapping Rodman's full service offering for small-cap issuers.
  • EF Hutton: EF Hutton is a boutique investment bank offering capital markets, advisory, and institutional sales services to small and mid-cap companies—closely comparable in target market and service breadth.
  • Aegis Capital Corp. Aegis Capital is a boutique broker-dealer providing investment banking, equity research, and institutional sales—directly comparable in service mix and small-cap issuer focus.
  • Ladenburg Thalmann: Ladenburg Thalmann operated as a comparable boutique investment bank with similar services in capital markets, research, and advisory for small and mid-cap issuers before its acquisition.
  • Roth Capital Partners: Roth Capital Partners is a closely comparable boutique investment bank specializing in PIPE/registered direct offerings, equity research, and institutional sales for small-cap and mid-cap companies, with comparable healthcare/biotech research franchise.
  • ThinkEquity: ThinkEquity is a boutique investment bank focused on capital markets, equity research, and institutional sales for emerging growth companies—a near-twin of Rodman's lower middle market positioning.
  • Alliance Global Partners (A.G.P.): A.G.P. is a direct peer operating as a boutique broker-dealer focused on PIPE transactions, equity research, and institutional sales for small and mid-cap issuers—overlapping directly in core service lines and target market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key highlights6 records

Customer concentration

Rodman & Renshaw social profiles

Digital presence

Rodman & Renshaw financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Rodman & Renshaw leadership team

Management profile

Number of profiles

Profiles3 records

Rodman & Renshaw funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Rodman & Renshaw M&A and investment

M&A and investment

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rodman & Renshaw

What does Rodman & Renshaw do?

Rodman & Renshaw is a boutique investment bank providing equity and debt financing, mergers and acquisitions advisory, and strategic advisory services to lower middle market growth companies across healthcare, technology, and energy sectors. The firm acts as a placement agent for registered directs, public offerings, private placements, and PIPEs, and operates a proprietary StockBlock electronic capital markets (eECM) platform that connects public company issuers with institutional investors for real-time capital formation. Complementary offerings include equity research distribution, institutional sales coverage, and corporate access non-deal road shows.

Is Rodman & Renshaw a public or private company?

Rodman & Renshaw is a private company. It is classified as unknown and is currently operating.

When was Rodman & Renshaw founded?

Rodman & Renshaw was founded in 1951. It employs 51 to 100 people.

Where is Rodman & Renshaw based?

Rodman & Renshaw is headquartered in New York, United States, in the North America region.

How does Rodman & Renshaw make money?

Four revenue lines are on record. Investment Banking / Placement Agent Fees are the primary driver. The others are broker-Dealer Services, strategic Advisory and capital Markets Transaction Fees.

Who are Rodman & Renshaw's main competitors?

Broad incumbents on record are Oppenheimer & Co., B. Riley Financial and Jefferies Financial Group. Direct peers are Maxim Group, EF Hutton, Aegis Capital Corp., Ladenburg Thalmann, Roth Capital Partners, ThinkEquity and Alliance Global Partners (A.G.P.).

Does Rodman & Renshaw have an API?

No public API is recorded for Rodman & Renshaw.

What industry is Rodman & Renshaw in?

Rodman & Renshaw's product category is Boutique Investment Banking. Its primary akta.pro industry code is FSAEALAL, Public & PIPE Capital Raising Intermediation (IPO Follow-ons/Convertibles/PIPES), with a secondary code of FSAEAIAB, Lower Middle-Market Business Brokerage. Its NAICS code is 52315 and its SIC code is 6211.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
American Banking and Market NewsQuince Therapeutics (NASDAQ:QNCX) Research Coverage Started at Rodman & RenshawRodman & Renshaw initiated coverage on Quince Therapeutics with a buy rating and $70 target. The stock opened at $31, and the company reported a loss of $12.31 per share, beating the consensus estimate of $28.02. Analysts have a consensus rating of Moderate Buy with an average target of $206.71.FinancialContent Business PageMissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Announces that Rodman & Renshaw Initiates Coverage with Buy Rating, $8 Price TargetRodman & Renshaw initiated coverage of Quantum BioPharma with a Buy rating and $8 price target. The report was led by Michael G. King Jr. and was unpaid, with no consideration or fees. Quantum BioPharma develops treatments for neurodegenerative and metabolic disorders.Stock TitanQuantum BioPharma Gets Rodman BUY Rating, $8 TargetRodman & Renshaw initiated coverage of Quantum BioPharma with a BUY rating and a US$8 price target. The company holds a 19.48% stake in Unbuzzd Wellness, with royalties of 7% of sales until $250 million is reached, then 3%.AdvfnQuantum BioPharma (NASDAQ: QNTM) Announces that Rodman & Renshaw Initiates Coverage with Buy Rating, $8 Price TargetRodman & Renshaw initiated coverage of Quantum BioPharma with a Buy rating and $8 price target. The report was led by Michael G. King Jr. and is unpaid. Quantum's lead compound Lucid-MS targets myelin degradation in multiple sclerosis.TipranksQuantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Draws ‘Buy’ Rating on Lucid-MS PotentialRodman & Renshaw initiated coverage of Quantum BioPharma with a Buy rating and an $8.00 price target, citing its Lucid-MS drug candidate. Lucid-MS is a non-immunomodulatory small molecule for progressive multiple sclerosis, with preclinical data showing it prevents and reverses myelin degradation.AInvestWETO Crater 43% as Equity Offering Looms: A Capital Structure ShockwaveWetour Robotics (WETO) fell 43.45% to $16.01 on August 26, 2026, after announcing an at-the-market equity offering with Rodman & Renshaw LLC under its Form F-3 shelf registration. The deal, allowing up to 3% commissions, triggered 42.69% intraday turnover and a $24.13-to-$16.00 swing amid dilution fears. The Hotels, Restaurants & Leisure sector weakened, with Airbnb down 1.18%.Investing.comEledon Pharmaceuticals stock initiated at Buy by Rodman & Renshaw By Investing.comRodman & Renshaw initiated coverage on Eledon Pharmaceuticals with a Buy rating and a $12 price target, implying approximately 200% upside from the current stock price of $3.86. The firm highlighted Eledon's lead drug candidate tegoprubart, an anti-CD40L antibody for organ transplantation, with a Phase 3 trial in kidney transplantation expected to begin by year-end and topline data anticipated in the second half of 2029. Eledon holds $111 million in cash providing runway into Q2 2027 and has recently received positive FDA feedback on a type 1 diabetes collaboration with NewcelX, partnered with Natera for its Phase 3 trial, and presented favorable long-term data from its Phase 2 BESTOW study.Investing.comEledon Pharmaceuticals stock initiated at Buy by Rodman & Renshaw By Investing.comRodman & Renshaw initiated coverage on Eledon Pharmaceuticals with a Buy rating and a $12 price target, implying approximately 200% upside from the current stock price of $3.86. The firm is developing tegoprubart, an anti-CD40L antibody for kidney transplantation, with a Phase 3 trial expected to start by the end of this year and topline data anticipated in the second half of 2029. Eledon holds approximately $111 million in cash providing runway into the second quarter of 2027, and the company has also received positive FDA feedback on its type 1 diabetes treatment collaboration with NewcelX.Investing.comRodman & Renshaw initiates vTv Therapeutics stock with buy rating By Investing.comRodman & Renshaw initiated coverage on vTv Therapeutics Inc. (NASDAQ:VTVT) with a buy rating and a $67.00 price target, citing the commercial potential of cadisegliatin (TTP399), a first-in-class oral glucokinase activator for Type 1 diabetes with FDA Breakthrough Therapy designation. Phase 2 data demonstrated improved HbA1c, fewer hypoglycemic events, and no increase in diabetic ketoacidosis. The Phase 3 CATT1 trial is expected to report topline results in mid-2027.Investing.comRodman & Renshaw initiates Neurogene stock with buy on gene therapy By Investing.comRodman & Renshaw initiated coverage on Neurogene Inc. (NASDAQ:NGNE) with a Buy rating and a $70 price target, implying approximately 170% upside from current levels, with the consensus rating across the analyst community standing at Strong Buy. Neurogene's lead asset NGN-401 is a one-time gene therapy for Rett syndrome currently being evaluated in the Phase 3 EMBOLDEN trial, with 12-month topline data anticipated in the second half of 2027. The company has approximately $243 million in cash, which is guided to fund operations past this key readout into the first quarter of 2028, while its current valuation stands at approximately $435 million.